首页> 外文期刊>Progress in Artificial Intelligence >Antimycobacterial screening of selected medicinal plants against Mycobacterium tuberculosis H37Rv using agar dilution method and the microplate resazurin assay
【24h】

Antimycobacterial screening of selected medicinal plants against Mycobacterium tuberculosis H37Rv using agar dilution method and the microplate resazurin assay

机译:用琼脂稀释法对结核分枝杆菌H37RV的抗细菌筛选治疗结核分枝杆菌H37RV和微孔板脱氮素测定

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Background: Tuberculosis (TB), has been serious disease to the global human population causing millions of deaths worldwide. The recent increase in the number of multi-drug resistant clinical isolates of Mycobacterium tuberculosis has created an urgent need for the discovery and development of new anti-TB drugs. Medicinal plants have had a great influence on the daily lives of people living in developing countries, particularly in India. Medicinal plants were selected, and they were evaluated for its anti-TB activity against the pathogenic strain of M. tuberculosis H37Rv. Methods: Eleven medicinal plants were selected on the basis of its literature survey, and three different extracts were prepared. Antimycobacterial activities were screened using two in vitro assays, namely agar dilution assay and microplate resazurin assay against M. tuberculosis H37Rv at different concentrations of prepared extracts. We analyzed minimal inhibition concentrations and percentage of inhibition of the used strain of Mycobacteria. Isoniazid was used as a standard anti-TB drug. Results: The results of this study showed that aqueous extracts four selected medicinal plants Ocimum sanctum, Adhatoda vasica, Leptadenia reticulata, and Cocculus hirsutus having minimum inhibitory concentration at 500 mu g/ml, 500 mu g/ml, 250 mu g/ml, and 250 mu g/ml, respectively, and O. sanctum (60.24%), A. vasica (62.89%), L. reticulata (74.26%), and C. hirsutus (81.67%) showed significant anti-TB activity against M. tuberculosis. Conclusion: This study helps society to found new anti-TB agents having better anti-TB activity with lesser or no side effects.
机译:背景:结核病(TB),对全球人口的严重疾病导致全球数百万死亡。近期分枝杆菌的多药物抗性临床分离株数量的增加产生了迫切需要发现和开发新的抗结核药物。药用植物对居住在发展中国家的人们的日常生活产生了很大影响,特别是在印度。选择药用植物,并评估其抗结核病活性的抗结核病活性,抗结核菌株H37RV。方法:在其文献调查的基础上选择11种药用植物,并制备三种不同的提取物。使用两种体外测定筛选抗细菌活性,即琼脂稀释试验和微孔板转基因测定,以不同浓度的制备的提取物。我们分析了最小的抑制浓度和抑制二手分枝杆菌的抑制百分比。 Isoniazid被用作标准的抗TB药物。结果:该研究的结果表明,水性提取物四种选定的药用植物OC0 Sanctum,Adhatoda vasica,Leptadenia reticulata,以及具有500μmg/ ml,500μmg/ ml,250μmg/ ml的最小抑制浓度的Cocculus hirsutus,分别为250μmg/ ml,和O. sanctum(60.24%),A. vasica(62.89%),L. reticulata(74.26%)和C. hirsutus(81.67%)对m表示显着的抗结核病活动。结核病。结论:本研究有助于社会发现具有更好的抗TB活性的新的抗TB药剂,副作用或没有副作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号